1-5 of 5
Vivek Verma, MD
Close
Sort by
Journal Articles

Validation of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) Score for Hypomethylating Agents (HMAs) Use in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)

Michelle Deveaux, Maximilian Stahl, MD, Pau Montesinos, MD PhD, Raphael Itzykson, MD PhD, Ellen K Ritchie, MD, Mikkael A. Sekeres, MD MS, John Barnard, PhD, Nikolai A. Podoltsev, MD PhD, Andrew M. Brunner, MD, Rami S. Komrokji, MD, Vijaya R. Bhatt, MBBS, Aref Al-Kali, MD, Thomas Cluzeau, MDPhD, Valeria Santini, MD, Gail J. Roboz, MD, Pierre Fenaux, MD PhD, Mark R. Litzow, MD, Amir T. Fathi, MD MD BS, Sera Perreault, PharmD, Tae Kon Kim, MD PhD, Thomas Prebet, MD PhD, Norbert Vey, Vivek Verma, MD, Ulrich Germing, MD, Juan Bergua, MD, Josefina Serrano, MD, Steven D. Gore, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3385.
https://doi.org/10.1182/blood.V130.Suppl_1.3385.3385
Published: 2017
Journal Articles

Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)— Transplant Outcomes Post HMA Therapy in a Large International Patient Cohort

Maximilian Stahl, MD, Michelle Deveaux, Pau Montesinos, MD PhD, Raphael Itzykson, MD PhD, Ellen K Ritchie, MD, Mikkael A. Sekeres, MD MS, Navneet S. Majhail, MD MS, Nikolai A. Podoltsev, MD PhD, Amir T. Fathi, MD MD BS, Rami S. Komrokji, MD, Vijaya R. Bhatt, MD, Aref Al-Kali, MD, Thomas Cluzeau, MDPhD, Valeria Santini, MD, Andrew M. Brunner, MD, Gail J. Roboz, MD, Pierre Fenaux, MD PhD, Mark R. Litzow, MD, Sera Perreault, PharmD, Tae Kon Kim, MD PhD, Thomas Prebet, MD PhD, Norbert Vey, Vivek Verma, MD, Guido Kobbe, MD, Juan Bergua, MD, Josefina Serrano, MD, Steven D. Gore, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3306.
https://doi.org/10.1182/blood.V130.Suppl_1.3306.3306
Published: 2017
Journal Articles

The Use of Immunosuppressive Therapy (IST) in Patients with the Myelodysplastic Syndromes (MDS): Clinical Outcomes and Their Predictors in a Large International Patient Cohort

Maximilian Stahl, MD, Michelle Deveaux, T. M. M de Witte, MD PhD, Judith Neukirchen, MD, Mikkael A. Sekeres, MD MS, Andrew M. Brunner, MD, Gail J. Roboz, MD, David P. Steensma, MD, Vijaya R. Bhatt, MD, Uwe Platzbecker, MD, Thomas Cluzeau, MDPhD, Pedro H Prata, MD, Pierre Fenaux, MD PhD, Amir T. Fathi, MD MD BS, Alex Smith, PhD, Ulrich Germing, MD, Ellen K Ritchie, MD, Vivek Verma, MD, Nikolai A. Podoltsev, MD PhD, Leonor Arenillas, MD, Thomas Prebet, MD PhD, Valeria Santini, MD, Steven D. Gore, MD, Rami S. Komrokji, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 422.
https://doi.org/10.1182/blood.V130.Suppl_1.422.422
Published: 2017
Journal Articles

The Impact of the Administration Schedule and Mutational Profile on Outcomes of Patients with Relapsed and Refractory Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Large, International, Multi-Center Analysis

Maximilian Stahl, MD, Michelle Deveaux, Pau Montesinos, MD PhD, Raphael Itzykson, MD PhD, Ellen K Ritchie, MD, Mikkael A. Sekeres, MD MS, Nikolai A. Podoltsev, MD PhD, Amir T. Fathi, MD MD BS, Rami S. Komrokji, MD, Vijaya R. Bhatt, MD, Aref Al-Kali, MD, Thomas Cluzeau, MDPhD, Valeria Santini, MD, Andrew M. Brunner, MD, Gail J. Roboz, MD, Pierre Fenaux, MD PhD, Mark R. Litzow, MD, Sera Perreault, PharmD, Tae Kon Kim, MD PhD, Thomas Prebet, MD PhD, Norbert Vey, Vivek Verma, MD, Ulrich Germing, MD, Juan Bergua, MD, Josefina Serrano, MD, Steven D. Gore, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 148.
https://doi.org/10.1182/blood.V130.Suppl_1.148.148
Published: 2017
Journal Articles

The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort

Maximilian Stahl, MD, Nikolai A Podoltsev, MD PhD, Michelle DeVeaux, Sarah Perreault, Pharm.D., BCPS, BCOP, Raphaël Itzykson, MD PhD, Ellen K. Ritchie, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Rami S. Komrokji, MD, Vijaya R. Bhatt, MD, Aref Al-Kali, MD, Thomas Cluzeau, Valeria Santini, MD, Andrew Brunner, MD, Gail J. Roboz, Pierre Fenaux, MD PhD, Mark Litzow, MD, Norbert Vey, Vivek Verma, MD, Ulrich Germing, M. D., Pau Montesinos Fernández, MD, Daniel Zelterman, PhD, Tae Kon Kim, MD PhD, Thomas Prebet, MD PhD, Steven D Gore, MD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2016) 128 (22): 1063.
https://doi.org/10.1182/blood.V128.22.1063.1063
Published: 2016